Purdue, other drugmakers race to launch tamper-resistant drugs

04/28/2008 | Bloomberg11

Purdue Pharma LP next week will present a new formulation of its painkiller OxyContin to a panel of outside advisers to the FDA, as it competes with other companies to introduce tamper-resistant drugs that addicts cannot abuse. Alpharma, Pain Therapeutics and Elite Pharmaceuticals are working on alternative treatments to capture a share of a market that could be worth $1 billion.

View Full Article in:

Bloomberg11

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC